Clinical trial

Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia

NCT00064194

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIETARY_SUPPLEMENT · Unmapped registry intervention selenium Find medicine records · Find other trials using this name

DIETARY_SUPPLEMENT · Unmapped registry intervention soy protein isolate Find medicine records · Find other trials using this name

DIETARY_SUPPLEMENT · Unmapped registry intervention vitamin E Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-11-28

PhasePHASE3

Conditions

Precancerous/Nonmalignant Conditionunresolved

Prostate Cancerverified · MONDO: prostate cancer

Interventions

seleniumDIETARY_SUPPLEMENT

soy protein isolateDIETARY_SUPPLEMENT

vitamin EDIETARY_SUPPLEMENT

Sponsors & collaborators

NCIC Clinical Trials Grouplead sponsor

Mapped research locations

TorontoOntario, Canada2 HalifaxNova Scotia, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00064194 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.